Bivalirudin reduces hemorrhagic complications and glycoprotein IIB/IIIA inhibitor usage in coronary intervention: Results from the NYU bivalirudin registry

Adjusted Rates of Primruy PC1 Use (% of all AM1 Patients) 1005A-219 Bivalirudin Reduces Hemorrhagic Complications and Glycoprotein IlBllllA Inhibitor Usage in Coronary Intervention: Results From the NYU Bivalirudin Registry Country (Province) 199